Carla A. Donatelli

Novel ATP-competitive kinesin spindle protein inhibitors.

Nicholas D. Adams, K. Wood, J. Finer, 2007, Journal of medicinal chemistry.

Discovery of a new series of Aurora inhibitors through truncation of GSK1070916.

Ramona N Plant, M. A. Hardwicke, J. Axten, 2010, Bioorganic & medicinal chemistry letters.

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.

J. D. Elliott, Nicholas D. Adams, X. Qian, 2010, ACS medicinal chemistry letters.

Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).

Carl A. Brooks, D. Holt, D. Behm, 2018, Journal of medicinal chemistry.

Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase.

Nicholas D. Adams, Ramona N Plant, J. Adams, 2010, Journal of medicinal chemistry.

Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions.

D. Holt, R. Rivero, A. Shu, 2020, Journal of medicinal chemistry.

Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.

Kaushik Raha, Dashyant Dhanak, David Sutton, 2010, ACS medicinal chemistry letters.

Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema Model.

Carl A. Brooks, D. Holt, D. Behm, 2018, Journal of medicinal chemistry.